Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03779542
Other study ID # HM-AOD-HZ
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date January 1, 2018
Est. completion date June 2019

Study information

Verified date December 2018
Source Wenzhou Medical University
Contact Man Hu, MD
Phone +86-0571-88185666
Email 64344308@qq.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

To assess the changes of anterior chamber angle in patients with shallow anterior chamber and normal anterior chamber after phacoemulsification and intraocular lens implantation (IOL) using anterior segment swept-source optical coherence tomography (AS-SS-OCT).To observe the 60 eyes of 60 patients in our study.


Description:

This is a prospective case-control study; 60 eyes of 60 patients who underwent cataract surgery. Based on anterior chamber depth (ACD) and gonioscopy findings, the eyes are classified into two groups, shallow anterior chamber group (30 eyes) and narrow anterior chamber group (30 eyes). AS-SS-OCT was used to measure ACD and angle parameters (angle opening distance(AOD), angle recess area(ARA), trabecular iris space area(TISA), and trabecular iris angle (TIA). Serial changes in each group were measured before and 3 months after phacoemulsification and IOL, and the differences between the two groups were compared.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date June 2019
Est. primary completion date June 30, 2018
Accepts healthy volunteers No
Gender All
Age group 40 Years to 85 Years
Eligibility Inclusion Criteria: patients who underwent cataract surgery -

Exclusion Criteria:patients with mild cataracts do not require surgery

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
cataract surgery
phacoemulsification and intraocular lens implantation

Locations

Country Name City State
China Eye Hospital of Wenzhou Medical College Wenzhou Zhejiang

Sponsors (1)

Lead Sponsor Collaborator
Yune Zhao

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary anterior chamber depth 1 year
See also
  Status Clinical Trial Phase
Completed NCT04702802 - Clinical Study to Evaluate the Safety of the Viscoelastic Substance PRO-149 When Used During Phacoemulsification, Compared to Healon® EndoCoat. Phase 1
Completed NCT03054103 - Sedation Methods During Cataract Surgery Phase 4
Completed NCT01146964 - Comparison of Manual Super Small Incision Cataract Surgery and Phacoemulsification N/A
Terminated NCT00690222 - Intracameral Mydriasis Versus Topical Mydriasis in Cataract Surgery N/A
Completed NCT03031652 - Clinical Analysis of Ocular Parameters Contributing to Intraoperative Pain During Standard Phacoemulsification N/A
Suspended NCT02590523 - Intracameral Antibiotic Safety Study Phase 3
Completed NCT01381783 - Phacoemulsification Under Topical Anesthesia and Its Complications Phase 1
Not yet recruiting NCT04711642 - Comprehensive Study on Dry Eye and Ocular Surface Disease Prior and After Cataract Surgery Phase 3
Completed NCT05529485 - Quantification of Factors Influencing Endothelial Damage During Phacoemulsification
Completed NCT03587909 - FLACS vs Phaco in Shallow Anterior Chamber N/A
Completed NCT03364972 - A Study Comparing Two Monofocal, Aspheric, Hydrophobic Acrylic Intraocular Lenses: the Alcon CLAREON® and the Abbott Medical Optics PCB00 N/A
Recruiting NCT03761745 - Rotational Stability of Different Intraocular Lenses in The Capsular Bag
Completed NCT00781027 - Fuchs' Torsional Phaco Study Phase 4
Completed NCT03972670 - Correlation Between Postoperative Central Corneal Thickness and Endothelial Damage After Cataract Surgery
Completed NCT01247155 - First Postoperative Day Review After Uneventful Phacoemulsification N/A